Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 1/2015

01-08-2015

The Clinical Features of Sarcoidosis: A Comprehensive Review

Author: Marc A. Judson

Published in: Clinical Reviews in Allergy & Immunology | Issue 1/2015

Login to get access

Abstract

Sarcoidosis has innumerable clinical manifestations, as the disease may affect every body organ. Furthermore, the severity of sarcoidosis involvement may range from an asymptomatic state to a life-threatening condition. This manuscript reviews a wide variety of common and less common clinical characteristics of sarcoidosis. These manifestations are presented organ by organ, although additional sections describe systemic and multiorgan presentations of sarcoidosis. The lung is the organ most commonly involved with sarcoidosis with at least 90 % of sarcoidosis patients demonstrating lung involvement in most series. The skin, eye, liver, and peripheral lymph node are the next most commonly clinically involved organs in most series, with the frequency of involvement ranging from 10 to 30 %. The actual frequency of sarcoidosis organ involvement is probably much higher as it is frequently asymptomatic and may avoid detection. This is particularly common with lung, liver, cardiac, and bone involvement. Cardiac sarcoidosis is present in 25 % of all sarcoidosis but only causes clinical problems in 5 % of them. Nevertheless, unlike sarcoidosis involvement of most other organs, it may be suddenly fatal. Therefore, it is important to screen for cardiac sarcoidosis in all sarcoidosis patients. All sarcoidosis patients should also be screened for eye involvement as asymptomatic patients may have eye involvement that may cause permanent vision impairment. Pulmonary fibrosis from sarcoidosis is usually slowly progressive but may be life-threatening because of the development of respiratory failure, pulmonary hypertension, or hemoptysis related to a mycetoma or bronchiectasis. Some manifestations of sarcoidosis are not organ-specific and probably are the result of a release of mediators from the sarcoid granuloma. Two such manifestations include small fiber neuropathy and fatigue syndromes, and they are observed in a large percentage of patients.
Literature
1.
go back to reference Prasse A, Katic C, Germann M et al (2008) Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 177:330–336PubMed Prasse A, Katic C, Germann M et al (2008) Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 177:330–336PubMed
2.
go back to reference Chappell AG, Cheung WY, Hutchings HA (2000) Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis 17:167–173PubMed Chappell AG, Cheung WY, Hutchings HA (2000) Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis 17:167–173PubMed
3.
go back to reference Baughman RP, Nagai S, Balter M et al (2011) Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis 28:56–64PubMed Baughman RP, Nagai S, Balter M et al (2011) Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis 28:56–64PubMed
4.
go back to reference Shlobin OA, Nathan SD (2012) Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation. Eur Respir J 39:1520–1533PubMed Shlobin OA, Nathan SD (2012) Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation. Eur Respir J 39:1520–1533PubMed
5.
go back to reference Swigris JJ, Olson AL, Huie TJ et al (2011) Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 183:1524–1530PubMedCentralPubMed Swigris JJ, Olson AL, Huie TJ et al (2011) Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 183:1524–1530PubMedCentralPubMed
6.
go back to reference Huang CT, Heurich AE, Sutton AL et al (1981) Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis 62:231–238PubMed Huang CT, Heurich AE, Sutton AL et al (1981) Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis 62:231–238PubMed
7.
go back to reference Arcasoy SM, Christie JD, Pochettino A et al (2001) Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 120:873–880PubMed Arcasoy SM, Christie JD, Pochettino A et al (2001) Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 120:873–880PubMed
8.
go back to reference Tavora F, Cresswell N, Li L et al (2009) Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 104:571–577PubMed Tavora F, Cresswell N, Li L et al (2009) Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 104:571–577PubMed
9.
go back to reference Iwai K, Sekiguti M, Hosoda Y et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed Iwai K, Sekiguti M, Hosoda Y et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed
10.
go back to reference Westney GE, Judson MA (2006) Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med 27:453–462, viPubMed Westney GE, Judson MA (2006) Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med 27:453–462, viPubMed
11.
go back to reference Sartwell PE, Edwards LB (1974) Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol 99:250–257PubMed Sartwell PE, Edwards LB (1974) Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol 99:250–257PubMed
12.
go back to reference Judson MA, Boan AD, Lackland DT (2012) The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis 29:119–127PubMed Judson MA, Boan AD, Lackland DT (2012) The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis 29:119–127PubMed
13.
go back to reference Edmondstone WM, Wilson AG (1985) Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest 79:27–36PubMed Edmondstone WM, Wilson AG (1985) Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest 79:27–36PubMed
14.
go back to reference Reich JM, Brouns MC, O’Connor EA et al (1998) Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest 113:147–153PubMed Reich JM, Brouns MC, O’Connor EA et al (1998) Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest 113:147–153PubMed
15.
go back to reference McKinzie BP, Bullington WM, Mazur JE et al (2010) Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. Am J Med Sci 339:1–4PubMed McKinzie BP, Bullington WM, Mazur JE et al (2010) Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. Am J Med Sci 339:1–4PubMed
16.
go back to reference Kalkanis A, Judson MA (2013) Distinguishing asthma from sarcoidosis: an approach to a problem that is not always solvable. J Asthma 50:1–6PubMed Kalkanis A, Judson MA (2013) Distinguishing asthma from sarcoidosis: an approach to a problem that is not always solvable. J Asthma 50:1–6PubMed
17.
go back to reference Shorr AF, Torrington KG, Hnatiuk OW (2001) Endobronchial biopsy for sarcoidosis: a prospective study. Chest 120:109–114PubMed Shorr AF, Torrington KG, Hnatiuk OW (2001) Endobronchial biopsy for sarcoidosis: a prospective study. Chest 120:109–114PubMed
18.
go back to reference Highland KB, Retalis P, Coppage L et al (1997) Is there an anatomic explanation for chest pain in patients with pulmonary sarcoidosis? South Med J 90:911–914PubMed Highland KB, Retalis P, Coppage L et al (1997) Is there an anatomic explanation for chest pain in patients with pulmonary sarcoidosis? South Med J 90:911–914PubMed
19.
go back to reference Nishino M, Lee KS, Itoh H et al (2010) The spectrum of pulmonary sarcoidosis: variations of high-resolution CT findings and clues for specific diagnosis. Eur J Radiol 73:66–73PubMed Nishino M, Lee KS, Itoh H et al (2010) The spectrum of pulmonary sarcoidosis: variations of high-resolution CT findings and clues for specific diagnosis. Eur J Radiol 73:66–73PubMed
20.
go back to reference Oberstein A, von Zitzewitz H, Schweden F et al (1997) Non invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography. Sarcoidosis Vasc Diffuse Lung Dis 14:65–72PubMed Oberstein A, von Zitzewitz H, Schweden F et al (1997) Non invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography. Sarcoidosis Vasc Diffuse Lung Dis 14:65–72PubMed
21.
go back to reference Muller NL, Kullnig P, Miller RR (1989) The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol 152:1179–1182PubMed Muller NL, Kullnig P, Miller RR (1989) The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol 152:1179–1182PubMed
22.
go back to reference Hashimoto M, Watanabe O, Sato K et al (1996) The CT findings of pulmonary sarcoidosis. Tohoku J Exp Med 179:259–266PubMed Hashimoto M, Watanabe O, Sato K et al (1996) The CT findings of pulmonary sarcoidosis. Tohoku J Exp Med 179:259–266PubMed
23.
go back to reference Polychronopoulos VS, Prakash UB (2009) Airway involvement in sarcoidosis. Chest 136:1371–1380PubMed Polychronopoulos VS, Prakash UB (2009) Airway involvement in sarcoidosis. Chest 136:1371–1380PubMed
24.
go back to reference Yamada G, Aketa K, Takahashi H et al (2005) Endobronchial lesions of sarcoidosis. Intern Med 44:909–910PubMed Yamada G, Aketa K, Takahashi H et al (2005) Endobronchial lesions of sarcoidosis. Intern Med 44:909–910PubMed
25.
go back to reference Nunes H, Uzunhan Y, Freynet O et al (2012) Pulmonary hypertension complicating sarcoidosis. Presse Med 41:e303–316PubMed Nunes H, Uzunhan Y, Freynet O et al (2012) Pulmonary hypertension complicating sarcoidosis. Presse Med 41:e303–316PubMed
26.
go back to reference Lynch JP 3rd, Kazerooni EA, Gay SE (1997) Pulmonary sarcoidosis. Clin Chest Med 18:755–785PubMed Lynch JP 3rd, Kazerooni EA, Gay SE (1997) Pulmonary sarcoidosis. Clin Chest Med 18:755–785PubMed
27.
go back to reference Sones M, Israel HL (1960) Course and prognosis of sarcoidosis. Am J Med 29:84–93PubMed Sones M, Israel HL (1960) Course and prognosis of sarcoidosis. Am J Med 29:84–93PubMed
28.
go back to reference Scadding JG (1961) Prognosis of intrathoracic sarcoidosis in England. a review of 136 cases after five years’ observation. Br Med J 2:1165–1172PubMedCentralPubMed Scadding JG (1961) Prognosis of intrathoracic sarcoidosis in England. a review of 136 cases after five years’ observation. Br Med J 2:1165–1172PubMedCentralPubMed
29.
go back to reference Mana J, Salazar A, Manresa F (1994) Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 61:219–225PubMed Mana J, Salazar A, Manresa F (1994) Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 61:219–225PubMed
30.
go back to reference Judson MA (2008) Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am J Med Sci 335:26–33PubMed Judson MA (2008) Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am J Med Sci 335:26–33PubMed
31.
go back to reference Lynch JP 3rd, Ma YL, Koss MN et al (2007) Pulmonary sarcoidosis. Semin Respir Crit Care Med 28:53–74PubMed Lynch JP 3rd, Ma YL, Koss MN et al (2007) Pulmonary sarcoidosis. Semin Respir Crit Care Med 28:53–74PubMed
32.
go back to reference Lynch JP 3rd (2003) Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med 24:393–418PubMed Lynch JP 3rd (2003) Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med 24:393–418PubMed
33.
go back to reference Nishimura K, Itoh H, Kitaichi M et al (1995) CT and pathological correlation of pulmonary sarcoidosis. Semin Ultrasound CT MR 16:361–370PubMed Nishimura K, Itoh H, Kitaichi M et al (1995) CT and pathological correlation of pulmonary sarcoidosis. Semin Ultrasound CT MR 16:361–370PubMed
34.
go back to reference Nakatsu M, Hatabu H, Morikawa K et al (2002) Large coalescent parenchymal nodules in pulmonary sarcoidosis: “sarcoid galaxy” sign. AJR Am J Roentgenol 178:1389–1393PubMed Nakatsu M, Hatabu H, Morikawa K et al (2002) Large coalescent parenchymal nodules in pulmonary sarcoidosis: “sarcoid galaxy” sign. AJR Am J Roentgenol 178:1389–1393PubMed
35.
go back to reference Brauner MW, Grenier P, Mompoint D et al (1989) Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology 172:467–471PubMed Brauner MW, Grenier P, Mompoint D et al (1989) Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology 172:467–471PubMed
36.
go back to reference Abehsera M, Valeyre D, Grenier P et al (2000) Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 174:1751–1757PubMed Abehsera M, Valeyre D, Grenier P et al (2000) Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 174:1751–1757PubMed
37.
go back to reference Mostard RL, Verschakelen JA, van Kroonenburgh MJ et al (2013) Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis. Respir Med 107:439–447PubMed Mostard RL, Verschakelen JA, van Kroonenburgh MJ et al (2013) Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis. Respir Med 107:439–447PubMed
38.
go back to reference Mana J, Teirstein AS, Mendelson DS et al (1995) Excessive thoracic computed tomographic scanning in sarcoidosis. Thorax 50:1264–1266PubMedCentralPubMed Mana J, Teirstein AS, Mendelson DS et al (1995) Excessive thoracic computed tomographic scanning in sarcoidosis. Thorax 50:1264–1266PubMedCentralPubMed
39.
go back to reference Smith-Bindman R, Lipson J, Marcus R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078–2086PubMed Smith-Bindman R, Lipson J, Marcus R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078–2086PubMed
40.
go back to reference Panselinas E, Judson MA (2012) Acute pulmonary exacerbations of sarcoidosis. Chest 142:827–836PubMed Panselinas E, Judson MA (2012) Acute pulmonary exacerbations of sarcoidosis. Chest 142:827–836PubMed
41.
go back to reference Judson MA, Baughman RP, Thompson BW et al (2003) Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 20:204–211PubMed Judson MA, Baughman RP, Thompson BW et al (2003) Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 20:204–211PubMed
42.
go back to reference Baydur A, Alsalek M, Louie SG et al (2001) Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. Chest 120:102–108PubMed Baydur A, Alsalek M, Louie SG et al (2001) Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. Chest 120:102–108PubMed
43.
go back to reference Winterbauer RH, Hutchinson JF (1980) Use of pulmonary function tests in the management of sarcoidosis. Chest 78:640–647PubMed Winterbauer RH, Hutchinson JF (1980) Use of pulmonary function tests in the management of sarcoidosis. Chest 78:640–647PubMed
44.
go back to reference Bergin CJ, Bell DY, Coblentz CL et al (1989) Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests. Radiology 171:619–624PubMed Bergin CJ, Bell DY, Coblentz CL et al (1989) Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests. Radiology 171:619–624PubMed
45.
go back to reference Nardi A, Brillet PY, Letoumelin P et al (2011) Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J 38:1368–1373PubMed Nardi A, Brillet PY, Letoumelin P et al (2011) Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J 38:1368–1373PubMed
46.
go back to reference Teirstein AS, Siltzbach LE, Berger H (1976) Patterns of sarcoidosis in three population groups in New York City. Ann N Y Acad Sci 278:371–376PubMed Teirstein AS, Siltzbach LE, Berger H (1976) Patterns of sarcoidosis in three population groups in New York City. Ann N Y Acad Sci 278:371–376PubMed
47.
go back to reference Boros PW, Enright PL, Quanjer PH et al (2010) Impaired lung compliance and DL, CO but no restrictive ventilatory defect in sarcoidosis. Eur Respir J 36:1315–1322PubMed Boros PW, Enright PL, Quanjer PH et al (2010) Impaired lung compliance and DL, CO but no restrictive ventilatory defect in sarcoidosis. Eur Respir J 36:1315–1322PubMed
48.
go back to reference Baughman RP, Engel PJ, Taylor L et al (2010) Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest 138:1078–1085PubMed Baughman RP, Engel PJ, Taylor L et al (2010) Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest 138:1078–1085PubMed
49.
go back to reference Shorr AF, Davies DB, Nathan SD (2003) Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 124:922–928PubMed Shorr AF, Davies DB, Nathan SD (2003) Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 124:922–928PubMed
50.
go back to reference Handa T, Nagai S, Miki S et al (2006) Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 129:1246–1252PubMed Handa T, Nagai S, Miki S et al (2006) Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 129:1246–1252PubMed
51.
go back to reference Smith LJ, Lawrence JB, Katzenstein AA (1983) Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am J Med Sci 285:38–44PubMed Smith LJ, Lawrence JB, Katzenstein AA (1983) Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am J Med Sci 285:38–44PubMed
52.
go back to reference Swigris JJ, Olson AL, Huie TJ et al (2011) Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007. Chest 140:1261–1266PubMedCentralPubMed Swigris JJ, Olson AL, Huie TJ et al (2011) Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007. Chest 140:1261–1266PubMedCentralPubMed
53.
go back to reference Pena TA, Soubani AO, Samavati L (2011) Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature. Lung 189:167–172PubMed Pena TA, Soubani AO, Samavati L (2011) Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature. Lung 189:167–172PubMed
54.
go back to reference Rafferty P, Biggs BA, Crompton GK et al (1983) What happens to patients with pulmonary aspergilloma? Analysis of 23 cases. Thorax 38:579–583PubMedCentralPubMed Rafferty P, Biggs BA, Crompton GK et al (1983) What happens to patients with pulmonary aspergilloma? Analysis of 23 cases. Thorax 38:579–583PubMedCentralPubMed
55.
go back to reference Tomlinson JR, Sahn SA (1987) Aspergilloma in sarcoid and tuberculosis. Chest 92:505–508PubMed Tomlinson JR, Sahn SA (1987) Aspergilloma in sarcoid and tuberculosis. Chest 92:505–508PubMed
56.
go back to reference Lewis MM, Mortelliti MP, Yeager H Jr et al (2002) Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients. Sarcoidosis Vasc Diffuse Lung Dis 19:154–159PubMed Lewis MM, Mortelliti MP, Yeager H Jr et al (2002) Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients. Sarcoidosis Vasc Diffuse Lung Dis 19:154–159PubMed
57.
go back to reference Huggins JT, Doelken P, Sahn SA et al (2006) Pleural effusions in a series of 181 outpatients with sarcoidosis. Chest 129:1599–1604PubMed Huggins JT, Doelken P, Sahn SA et al (2006) Pleural effusions in a series of 181 outpatients with sarcoidosis. Chest 129:1599–1604PubMed
58.
go back to reference Tsiodras S, Eiger G, Guttentag A et al (1997) Sarcoidosis presenting as unilateral alveolar consolidation. Am J Med Sci 314:346–347PubMed Tsiodras S, Eiger G, Guttentag A et al (1997) Sarcoidosis presenting as unilateral alveolar consolidation. Am J Med Sci 314:346–347PubMed
59.
go back to reference Sharma SK, Soneja M, Sharma A et al (2012) Rare manifestations of sarcoidosis in modern era of new diagnostic tools. Indian J Med Res 135:621–629PubMedCentralPubMed Sharma SK, Soneja M, Sharma A et al (2012) Rare manifestations of sarcoidosis in modern era of new diagnostic tools. Indian J Med Res 135:621–629PubMedCentralPubMed
60.
go back to reference Ozseker ZF, Yilmaz A, Bayramgurler B et al (2002) Cavitary sarcoidosis: analysis of two cases. Respirology 7:289–291PubMed Ozseker ZF, Yilmaz A, Bayramgurler B et al (2002) Cavitary sarcoidosis: analysis of two cases. Respirology 7:289–291PubMed
61.
go back to reference Quaden C, Tillie-Leblond I, Delobbe A et al (2005) Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations. Eur Respir J 26:778–785PubMed Quaden C, Tillie-Leblond I, Delobbe A et al (2005) Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations. Eur Respir J 26:778–785PubMed
62.
go back to reference Churg A, Carrington CB, Gupta R (1979) Necrotizing sarcoid granulomatosis. Chest 76:406–413PubMed Churg A, Carrington CB, Gupta R (1979) Necrotizing sarcoid granulomatosis. Chest 76:406–413PubMed
63.
go back to reference Marlow TJ, Krapiva PI, Schabel SI et al (1999) The “fairy ring”: a new radiographic finding in sarcoidosis. Chest 115:275–276PubMed Marlow TJ, Krapiva PI, Schabel SI et al (1999) The “fairy ring”: a new radiographic finding in sarcoidosis. Chest 115:275–276PubMed
64.
go back to reference Marchiori E, Zanetti G, Duarte Guimaraes M (2014) The reversed halo sign extending the spectrum of atypical radiological manifestations in sarcoidosis. Ann Thorac Med 9:48PubMedCentralPubMed Marchiori E, Zanetti G, Duarte Guimaraes M (2014) The reversed halo sign extending the spectrum of atypical radiological manifestations in sarcoidosis. Ann Thorac Med 9:48PubMedCentralPubMed
65.
go back to reference Walsh SL, Roberton BJ (2010) Images in thorax. Atoll Sign Thorax 65:1029–1030 Walsh SL, Roberton BJ (2010) Images in thorax. Atoll Sign Thorax 65:1029–1030
66.
go back to reference Judson MA, Uflacker R (2001) Treatment of a solitary pulmonary sarcoidosis mass by CT-guided direct intralesional injection of corticosteroid. Chest 120:316–317PubMed Judson MA, Uflacker R (2001) Treatment of a solitary pulmonary sarcoidosis mass by CT-guided direct intralesional injection of corticosteroid. Chest 120:316–317PubMed
67.
go back to reference Steele JD (1963) The solitary pulmonary nodule. Report of a cooperative study of resected asymptomatic solitary pulmonary nodules in males. J Thorac Cardiovasc Surg 46:21–39PubMed Steele JD (1963) The solitary pulmonary nodule. Report of a cooperative study of resected asymptomatic solitary pulmonary nodules in males. J Thorac Cardiovasc Surg 46:21–39PubMed
68.
go back to reference Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889PubMed Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889PubMed
69.
go back to reference Dana MR, Merayo-Lloves J, Schaumberg DA et al (1996) Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 103:1846–1853PubMed Dana MR, Merayo-Lloves J, Schaumberg DA et al (1996) Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 103:1846–1853PubMed
70.
go back to reference Baughman RP, Lower EE, Kaufman AH (2010) Ocular sarcoidosis. Semin Respir Crit Care Med 31:452–462PubMed Baughman RP, Lower EE, Kaufman AH (2010) Ocular sarcoidosis. Semin Respir Crit Care Med 31:452–462PubMed
71.
go back to reference Evans M, Sharma O, LaBree L et al (2007) Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 114:325–333PubMed Evans M, Sharma O, LaBree L et al (2007) Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 114:325–333PubMed
72.
go back to reference Hunninghake GW, Costabel U, Ando M et al (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149–173PubMed Hunninghake GW, Costabel U, Ando M et al (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149–173PubMed
73.
go back to reference Ohara K, Judson MA, Baughman RP (2005) Clinical aspects of ocular sarcoidosis. Eur Respi J Monog 10:188–209 Ohara K, Judson MA, Baughman RP (2005) Clinical aspects of ocular sarcoidosis. Eur Respi J Monog 10:188–209
75.
go back to reference Bradley DA, Baughman RP, Raymond L et al (2002) Ocular manifestations of sarcoidosis. Sem Resp Crit Care Med 23:543–548 Bradley DA, Baughman RP, Raymond L et al (2002) Ocular manifestations of sarcoidosis. Sem Resp Crit Care Med 23:543–548
76.
go back to reference Mayers M (1990) Ocular sarcoidosis. Int Ophthalmol Clin 30:257–263PubMed Mayers M (1990) Ocular sarcoidosis. Int Ophthalmol Clin 30:257–263PubMed
77.
go back to reference Jabs DA, Johns CJ (1986) Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 102:297–301PubMed Jabs DA, Johns CJ (1986) Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 102:297–301PubMed
78.
go back to reference Yanardag H, Pamuk ON (2003) Lacrimal gland involvement in sarcoidosis. The clinical features of 9 patients. Swiss Med Wkly 133:388–391PubMed Yanardag H, Pamuk ON (2003) Lacrimal gland involvement in sarcoidosis. The clinical features of 9 patients. Swiss Med Wkly 133:388–391PubMed
79.
go back to reference Tannen BL, Kolomeyer AM, Turbin RE et al (2014) Lacrimal gland uptake of (67)Ga-gallium citrate correlates with biopsy results in patients with suspected sarcoidosis. Ocul Immunol Inflamm 22:15–22PubMed Tannen BL, Kolomeyer AM, Turbin RE et al (2014) Lacrimal gland uptake of (67)Ga-gallium citrate correlates with biopsy results in patients with suspected sarcoidosis. Ocul Immunol Inflamm 22:15–22PubMed
80.
go back to reference Prabhakaran VC, Saeed P, Esmaeli B et al (2007) Orbital and adnexal sarcoidosis. Arch Ophthalmol 125:1657–1662PubMed Prabhakaran VC, Saeed P, Esmaeli B et al (2007) Orbital and adnexal sarcoidosis. Arch Ophthalmol 125:1657–1662PubMed
81.
go back to reference Parma ES, Abrams JE, Bhattacharjee MB et al (2002) A nodular extraocular muscle lesion in a patient with sarcoidosis. J Pediatr Ophthalmol Strabismus 39:367–368PubMed Parma ES, Abrams JE, Bhattacharjee MB et al (2002) A nodular extraocular muscle lesion in a patient with sarcoidosis. J Pediatr Ophthalmol Strabismus 39:367–368PubMed
82.
go back to reference Marchall R, Thiers B, Judson MA. Sarcoidosis. In: Wolff K, Goldsmith LA, Katz SI, et al., eds. Fitzpatrick’s dermatology in general medicine. New York: McGraw Hill Medical, 2008; 1484-1493 Marchall R, Thiers B, Judson MA. Sarcoidosis. In: Wolff K, Goldsmith LA, Katz SI, et al., eds. Fitzpatrick’s dermatology in general medicine. New York: McGraw Hill Medical, 2008; 1484-1493
83.
go back to reference Eklund A, Rizzato G (2005) Skin manifestations in sarcoidosis. Eur Resp J Monog 10:150–163 Eklund A, Rizzato G (2005) Skin manifestations in sarcoidosis. Eur Resp J Monog 10:150–163
84.
go back to reference Mana J, Gomez-Vaquero C, Montero A et al (1999) Lofgren’s syndrome revisited: a study of 186 patients. Am J Med 107:240–245PubMed Mana J, Gomez-Vaquero C, Montero A et al (1999) Lofgren’s syndrome revisited: a study of 186 patients. Am J Med 107:240–245PubMed
85.
go back to reference Okamoto H, Mizuno K, Imamura S et al (1994) Erythema nodosum-like eruption in sarcoidosis. Clin Exp Dermatol 19:507–510PubMed Okamoto H, Mizuno K, Imamura S et al (1994) Erythema nodosum-like eruption in sarcoidosis. Clin Exp Dermatol 19:507–510PubMed
86.
go back to reference Grunewald J, Eklund A (2009) Lofgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 179:307–312PubMed Grunewald J, Eklund A (2009) Lofgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 179:307–312PubMed
87.
go back to reference Marchell RM, Judson MA (2007) Chronic cutaneous lesions of sarcoidosis. Clin Dermatol 25:295–302PubMed Marchell RM, Judson MA (2007) Chronic cutaneous lesions of sarcoidosis. Clin Dermatol 25:295–302PubMed
88.
go back to reference Haimovic A, Sanchez M, Judson MA (2012) Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol 66:699, e691-618; quiz 717-698PubMed Haimovic A, Sanchez M, Judson MA (2012) Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol 66:699, e691-618; quiz 717-698PubMed
89.
go back to reference Aubart FC, Ouayoun M, Brauner M et al (2006) Sinonasal involvement in sarcoidosis: a case–control study of 20 patients. Medicine (Baltimore) 85:365–371 Aubart FC, Ouayoun M, Brauner M et al (2006) Sinonasal involvement in sarcoidosis: a case–control study of 20 patients. Medicine (Baltimore) 85:365–371
90.
go back to reference Yanardag H, Pamuk ON, Karayel T (2003) Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 97:978–982PubMed Yanardag H, Pamuk ON, Karayel T (2003) Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 97:978–982PubMed
91.
go back to reference Neville E, Walker AN, James DG (1983) Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 52:525–533PubMed Neville E, Walker AN, James DG (1983) Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 52:525–533PubMed
92.
go back to reference Antonovich DD, Callen JP (2005) Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 141:869–872PubMed Antonovich DD, Callen JP (2005) Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 141:869–872PubMed
93.
go back to reference Chao SC, Yan JJ, Lee JY (2000) Cutaneous sarcoidosis among Taiwanese. J Formos Med Assoc 99:317–323PubMed Chao SC, Yan JJ, Lee JY (2000) Cutaneous sarcoidosis among Taiwanese. J Formos Med Assoc 99:317–323PubMed
94.
go back to reference Hsu S, Le EH, Khoshevis MR (2001) Differential diagnosis of annular lesions. Am Fam Physician 64:289–296PubMed Hsu S, Le EH, Khoshevis MR (2001) Differential diagnosis of annular lesions. Am Fam Physician 64:289–296PubMed
95.
go back to reference Elgart ML (1986) Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol 4:35–45PubMed Elgart ML (1986) Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol 4:35–45PubMed
96.
go back to reference Vainsencher D, Winkelmann RK (1984) Subcutaneous sarcoidosis. Arch Dermatol 120:1028–1031PubMed Vainsencher D, Winkelmann RK (1984) Subcutaneous sarcoidosis. Arch Dermatol 120:1028–1031PubMed
97.
go back to reference Ichiki Y, Kitajima Y (2008) Ulcerative sarcoidosis: case report and review of the Japanese literature. Acta Derm Venereol 88:526–528PubMed Ichiki Y, Kitajima Y (2008) Ulcerative sarcoidosis: case report and review of the Japanese literature. Acta Derm Venereol 88:526–528PubMed
98.
go back to reference Yoo SS, Mimouni D, Nikolskaia OV et al (2004) Clinicopathologic features of ulcerative–atrophic sarcoidosis. Int J Dermatol 43:108–112PubMed Yoo SS, Mimouni D, Nikolskaia OV et al (2004) Clinicopathologic features of ulcerative–atrophic sarcoidosis. Int J Dermatol 43:108–112PubMed
99.
go back to reference Sharma OP, Maheshwari A, Thaker K (1993) Myocardial sarcoidosis. Chest 103:253–258PubMed Sharma OP, Maheshwari A, Thaker K (1993) Myocardial sarcoidosis. Chest 103:253–258PubMed
100.
go back to reference Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathological study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211PubMed Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathological study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211PubMed
101.
go back to reference Birnie DH, Sauer WH, Bogun F et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305–1324PubMed Birnie DH, Sauer WH, Bogun F et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305–1324PubMed
102.
go back to reference Kim JS, Judson MA, Donnino R et al (2009) Cardiac sarcoidosis. Am Heart J 157:9–21PubMed Kim JS, Judson MA, Donnino R et al (2009) Cardiac sarcoidosis. Am Heart J 157:9–21PubMed
103.
go back to reference Chapelon-Abric C, de Zuttere D, Duhaut P et al (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83:315–334 Chapelon-Abric C, de Zuttere D, Duhaut P et al (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83:315–334
104.
go back to reference Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in The Netherlands. Chest 128:30–35PubMed Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in The Netherlands. Chest 128:30–35PubMed
105.
go back to reference Roberts WC, McAllister HA Jr, Ferrans VJ (1977) Sarcoidosis of the heart. a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 63:86–108PubMed Roberts WC, McAllister HA Jr, Ferrans VJ (1977) Sarcoidosis of the heart. a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 63:86–108PubMed
106.
go back to reference Winters SL, Cohen M, Greenberg S et al (1991) Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 18:937–943PubMed Winters SL, Cohen M, Greenberg S et al (1991) Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 18:937–943PubMed
107.
go back to reference Aizer A, Stern EH, Gomes JA et al (2005) Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 96:276–282PubMed Aizer A, Stern EH, Gomes JA et al (2005) Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 96:276–282PubMed
108.
go back to reference Viles-Gonzalez JF, Pastori L, Fischer A et al (2013) Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest 143:1085–1090PubMed Viles-Gonzalez JF, Pastori L, Fischer A et al (2013) Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest 143:1085–1090PubMed
109.
go back to reference Yazaki Y, Isobe M, Hiroe M et al (2001) Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88:1006–1010PubMed Yazaki Y, Isobe M, Hiroe M et al (2001) Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88:1006–1010PubMed
110.
go back to reference Blauwet LA, Cooper LT (2013) Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev 18:733–746PubMed Blauwet LA, Cooper LT (2013) Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev 18:733–746PubMed
111.
go back to reference Iwai K, Takemura T, Kitaichi M et al (1993) Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol Jpn 43:377–385PubMed Iwai K, Takemura T, Kitaichi M et al (1993) Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol Jpn 43:377–385PubMed
112.
go back to reference Desai MY, Fallert MA (2003) Rapidly progressing congestive heart failure due to cardiac sarcoidosis involving papillary muscles: a case report and brief review of the literature. Cardiol Rev 11:163–168PubMed Desai MY, Fallert MA (2003) Rapidly progressing congestive heart failure due to cardiac sarcoidosis involving papillary muscles: a case report and brief review of the literature. Cardiol Rev 11:163–168PubMed
113.
go back to reference Goyal SB, Aragam JR (2006) Cardiac sarcoidosis with primary involvement of the tricuspid valve. Cardiol Rev 14:e12–13PubMed Goyal SB, Aragam JR (2006) Cardiac sarcoidosis with primary involvement of the tricuspid valve. Cardiol Rev 14:e12–13PubMed
114.
go back to reference Gasparovic H, Bueno R, Rybicki FJ et al (2004) Sarcoidosis of the aortic root. J Thorac Cardiovasc Surg 128:761–762PubMed Gasparovic H, Bueno R, Rybicki FJ et al (2004) Sarcoidosis of the aortic root. J Thorac Cardiovasc Surg 128:761–762PubMed
115.
go back to reference Kinney E, Murthy R, Ascunce G et al (1979) Pericardial effusions in sarcoidosis. Chest 76:476–478PubMed Kinney E, Murthy R, Ascunce G et al (1979) Pericardial effusions in sarcoidosis. Chest 76:476–478PubMed
116.
go back to reference Wyplosz B, Marijon E, Dougados J et al (2010) Sarcoidosis: an unusual cause of acute pericarditis. Acta Cardiol 65:83–84PubMed Wyplosz B, Marijon E, Dougados J et al (2010) Sarcoidosis: an unusual cause of acute pericarditis. Acta Cardiol 65:83–84PubMed
117.
go back to reference Lam CS, Tolep KA, Metke MP et al (2009) Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol 32:E68–71PubMed Lam CS, Tolep KA, Metke MP et al (2009) Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol 32:E68–71PubMed
118.
go back to reference Butany J, Bahl NE, Morales K et al (2006) The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol 15:222–227PubMed Butany J, Bahl NE, Morales K et al (2006) The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol 15:222–227PubMed
119.
go back to reference Abrishami B, O’Connel C, Sharma O (2004) Cardiac sarcoidosis with presentation of large left atrial mass. Curr Opin Pulm Med 10:397–400PubMed Abrishami B, O’Connel C, Sharma O (2004) Cardiac sarcoidosis with presentation of large left atrial mass. Curr Opin Pulm Med 10:397–400PubMed
120.
go back to reference Ardehali H, Howard DL, Hariri A et al (2005) A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 150:459–463PubMed Ardehali H, Howard DL, Hariri A et al (2005) A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 150:459–463PubMed
121.
go back to reference Tadamura E, Yamamuro M, Kubo S et al (2005) Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185:110–115PubMed Tadamura E, Yamamuro M, Kubo S et al (2005) Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185:110–115PubMed
122.
go back to reference Bulkley BH, Rouleau JR, Whitaker JQ et al (1977) The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest 72:27–32PubMed Bulkley BH, Rouleau JR, Whitaker JQ et al (1977) The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest 72:27–32PubMed
123.
go back to reference Tellier P, Paycha F, Antony I et al (1988) Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 85:189–193PubMed Tellier P, Paycha F, Antony I et al (1988) Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 85:189–193PubMed
124.
go back to reference Le Guludec D, Menad F, Faraggi M (1994) Myocardial sarcoidosis. Clinical value of Technetium-99m Sestamibi tomoscintigraphy. Chest 106:1675–1682PubMed Le Guludec D, Menad F, Faraggi M (1994) Myocardial sarcoidosis. Clinical value of Technetium-99m Sestamibi tomoscintigraphy. Chest 106:1675–1682PubMed
125.
go back to reference Okayama K, Kurata C, Tawarahara K et al (1995) Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 107:330–334PubMed Okayama K, Kurata C, Tawarahara K et al (1995) Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 107:330–334PubMed
126.
go back to reference Ishimaru S, Tsujino I, Takei T et al (2005) Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26:1538–1543PubMed Ishimaru S, Tsujino I, Takei T et al (2005) Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26:1538–1543PubMed
127.
go back to reference Yokoyama I, Momomura S, Ohtake T et al (1998) Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy. Eur J Nucl Med 25:736–743PubMed Yokoyama I, Momomura S, Ohtake T et al (1998) Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy. Eur J Nucl Med 25:736–743PubMed
128.
go back to reference Shimada T, Shimada K, Sakane T et al (2001) Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 110:520–527PubMed Shimada T, Shimada K, Sakane T et al (2001) Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 110:520–527PubMed
129.
go back to reference Vignaux O, Dhote R, Duboc D et al (2002) Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 122:1895–1901PubMed Vignaux O, Dhote R, Duboc D et al (2002) Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 122:1895–1901PubMed
130.
go back to reference Vignaux O (2005) Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184:249–254PubMed Vignaux O (2005) Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184:249–254PubMed
131.
go back to reference Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683–1690PubMed Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683–1690PubMed
132.
go back to reference Tadamura E, Yamamuro M, Kubo S et al (2006) Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation 113:e771–773PubMed Tadamura E, Yamamuro M, Kubo S et al (2006) Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation 113:e771–773PubMed
133.
go back to reference Mehta D, Lubitz SA, Frankel Z et al (2008) Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133:1426–1435PubMed Mehta D, Lubitz SA, Frankel Z et al (2008) Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133:1426–1435PubMed
134.
go back to reference Ohira H, Tsujino I, Ishimaru S et al (2008) Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 35:933–941PubMed Ohira H, Tsujino I, Ishimaru S et al (2008) Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 35:933–941PubMed
135.
go back to reference Ahmadian A, Brogan A, Berman J, et al. (2014) Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol Ahmadian A, Brogan A, Berman J, et al. (2014) Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol
136.
go back to reference Isiguzo M, Brunken R, Tchou P et al (2011) Metabolism–perfusion imaging to predict disease activity in cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 28:50–55PubMed Isiguzo M, Brunken R, Tchou P et al (2011) Metabolism–perfusion imaging to predict disease activity in cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 28:50–55PubMed
137.
go back to reference Sharma OP (1997) Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 112:220–228PubMed Sharma OP (1997) Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 112:220–228PubMed
138.
go back to reference Stern BJ, Krumholz A, Johns C et al (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42:909–917PubMed Stern BJ, Krumholz A, Johns C et al (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42:909–917PubMed
139.
go back to reference Delaney P (1977) Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 87:336–345PubMed Delaney P (1977) Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 87:336–345PubMed
140.
go back to reference Lower EE, Broderick JP, Brott TG et al (1997) Diagnosis and management of neurological sarcoidosis. Arch Intern Med 157:1864–1868PubMed Lower EE, Broderick JP, Brott TG et al (1997) Diagnosis and management of neurological sarcoidosis. Arch Intern Med 157:1864–1868PubMed
141.
go back to reference Chen RC, McLeod JG (1989) Neurological complications of sarcoidosis. Clin Exp Neurol 26:99–112PubMed Chen RC, McLeod JG (1989) Neurological complications of sarcoidosis. Clin Exp Neurol 26:99–112PubMed
142.
go back to reference Nozaki K, Judson MA (2012) Neurosarcoidosis: clinical manifestations, diagnosis and treatment. Presse Med 41:e331–348PubMed Nozaki K, Judson MA (2012) Neurosarcoidosis: clinical manifestations, diagnosis and treatment. Presse Med 41:e331–348PubMed
143.
go back to reference Joseph FG, Scolding NJ (2009) Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry 80:297–304PubMed Joseph FG, Scolding NJ (2009) Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry 80:297–304PubMed
144.
go back to reference Zajicek JP, Scolding NJ, Foster O et al (1999) Central nervous system sarcoidosis—diagnosis and management. QJM 92:103–117PubMed Zajicek JP, Scolding NJ, Foster O et al (1999) Central nervous system sarcoidosis—diagnosis and management. QJM 92:103–117PubMed
145.
go back to reference Allen RK, Sellars RE, Sandstrom PA (2003) A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 20:118–125PubMed Allen RK, Sellars RE, Sandstrom PA (2003) A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 20:118–125PubMed
146.
go back to reference Colvin IB (2006) Audiovestibular manifestations of sarcoidosis: a review of the literature. Laryngoscope 116:75–82PubMed Colvin IB (2006) Audiovestibular manifestations of sarcoidosis: a review of the literature. Laryngoscope 116:75–82PubMed
147.
go back to reference Takahashi T, Fujita N, Takeda K et al (2000) A case of sarcoid myopathy with external ocular muscle involvement—diagnosis and follow-up study with 99mTc pyrophosphate scintigraphy. Rinsho Shinkeigaku 40:145–148PubMed Takahashi T, Fujita N, Takeda K et al (2000) A case of sarcoid myopathy with external ocular muscle involvement—diagnosis and follow-up study with 99mTc pyrophosphate scintigraphy. Rinsho Shinkeigaku 40:145–148PubMed
148.
go back to reference Biesman BS (1994) Extraocular muscle sarcoid. Ophthalmology 101:1–2PubMed Biesman BS (1994) Extraocular muscle sarcoid. Ophthalmology 101:1–2PubMed
149.
go back to reference Patel AS, Kelman SE, Duncan GW et al (1994) Painless diplopia caused by extraocular muscle sarcoid. Arch Ophthalmol 112:879–880PubMed Patel AS, Kelman SE, Duncan GW et al (1994) Painless diplopia caused by extraocular muscle sarcoid. Arch Ophthalmol 112:879–880PubMed
150.
go back to reference Gullapalli D, Phillips LH 2nd (2004) Neurosarcoidosis. Curr Neurol Neurosci Rep 4:441–447PubMed Gullapalli D, Phillips LH 2nd (2004) Neurosarcoidosis. Curr Neurol Neurosci Rep 4:441–447PubMed
151.
go back to reference Lower EE, Weiss KL (2008) Neurosarcoidosis. Clin Chest Med 29:475–492, ixPubMed Lower EE, Weiss KL (2008) Neurosarcoidosis. Clin Chest Med 29:475–492, ixPubMed
152.
go back to reference Hoitsma E, Faber CG, Drent M et al (2004) Neurosarcoidosis: a clinical dilemma. Lancet Neurol 3:397–407PubMed Hoitsma E, Faber CG, Drent M et al (2004) Neurosarcoidosis: a clinical dilemma. Lancet Neurol 3:397–407PubMed
153.
go back to reference Nozaki K, Scott TF, Sohn M et al (2012) Isolated neurosarcoidosis: case series in 2 sarcoidosis centers. Neurologist 18:373–377PubMed Nozaki K, Scott TF, Sohn M et al (2012) Isolated neurosarcoidosis: case series in 2 sarcoidosis centers. Neurologist 18:373–377PubMed
154.
go back to reference Galassi G, Gibertoni M, Mancini A et al (1984) Sarcoidosis of the peripheral nerve: clinical, electrophysiological and histological study of two cases. Eur Neurol 23:459–465PubMed Galassi G, Gibertoni M, Mancini A et al (1984) Sarcoidosis of the peripheral nerve: clinical, electrophysiological and histological study of two cases. Eur Neurol 23:459–465PubMed
155.
go back to reference Nemni R, Galassi G, Cohen M et al (1981) Symmetric sarcoid polyneuropathy: analysis of a sural nerve biopsy. Neurology 31:1217–1223PubMed Nemni R, Galassi G, Cohen M et al (1981) Symmetric sarcoid polyneuropathy: analysis of a sural nerve biopsy. Neurology 31:1217–1223PubMed
156.
go back to reference Bakkers M, Merkies IS, Lauria G et al (2009) Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 73:1142–1148PubMed Bakkers M, Merkies IS, Lauria G et al (2009) Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 73:1142–1148PubMed
157.
go back to reference Hoitsma E, Drent M, Verstraete E et al (2003) Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin Neurophysiol 114:2326–2333PubMed Hoitsma E, Drent M, Verstraete E et al (2003) Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin Neurophysiol 114:2326–2333PubMed
158.
go back to reference Tavee J, Culver D (2011) Sarcoidosis and small-fiber neuropathy. Curr Pain Headache Rep 15:201–206PubMed Tavee J, Culver D (2011) Sarcoidosis and small-fiber neuropathy. Curr Pain Headache Rep 15:201–206PubMed
159.
go back to reference Hoitsma E, Marziniak M, Faber CG et al (2002) Small fibre neuropathy in sarcoidosis. Lancet 359:2085–2086PubMed Hoitsma E, Marziniak M, Faber CG et al (2002) Small fibre neuropathy in sarcoidosis. Lancet 359:2085–2086PubMed
160.
go back to reference Parambil JG, Tavee JO, Zhou L et al (2011) Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med 105:101–105PubMed Parambil JG, Tavee JO, Zhou L et al (2011) Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med 105:101–105PubMed
161.
go back to reference Westhout FD, Linskey ME (2008) Obstructive hydrocephalus and progressive psychosis: rare presentations of neurosarcoidosis. Surg Neurol 69:288–292, discussion 292PubMed Westhout FD, Linskey ME (2008) Obstructive hydrocephalus and progressive psychosis: rare presentations of neurosarcoidosis. Surg Neurol 69:288–292, discussion 292PubMed
162.
go back to reference Krumholz A, Stern BJ, Stern EG (1991) Clinical implications of seizures in neurosarcoidosis. Arch Neurol 48:842–844PubMed Krumholz A, Stern BJ, Stern EG (1991) Clinical implications of seizures in neurosarcoidosis. Arch Neurol 48:842–844PubMed
163.
go back to reference Murialdo G, Tamagno G (2002) Endocrine aspects of neurosarcoidosis. J Endocrinol Invest 25:650–662PubMed Murialdo G, Tamagno G (2002) Endocrine aspects of neurosarcoidosis. J Endocrinol Invest 25:650–662PubMed
164.
go back to reference Irani SK, Dobbins WO 3rd (1979) Hepatic granulomas: review of 73 patients from one hospital and survey of the literature. J Clin Gastroenterol 1:131–143PubMed Irani SK, Dobbins WO 3rd (1979) Hepatic granulomas: review of 73 patients from one hospital and survey of the literature. J Clin Gastroenterol 1:131–143PubMed
165.
go back to reference Vatti R, Sharma OP (1997) Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis 14:73–76PubMed Vatti R, Sharma OP (1997) Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis 14:73–76PubMed
166.
go back to reference James DG, Sherlock S (1994) Sarcoidosis of the liver. Sarcoidosis 11:2–6PubMed James DG, Sherlock S (1994) Sarcoidosis of the liver. Sarcoidosis 11:2–6PubMed
167.
go back to reference Klatskin G (1977) Hepatic granulomata: problems in interpretation. Mt Sinai J Med 44:798–812PubMed Klatskin G (1977) Hepatic granulomata: problems in interpretation. Mt Sinai J Med 44:798–812PubMed
168.
go back to reference Israel HL, Margolis ML, Rose LJ (1984) Hepatic granulomatosis and sarcoidosis. Further observations. Dig Dis Sci 29:353–356PubMed Israel HL, Margolis ML, Rose LJ (1984) Hepatic granulomatosis and sarcoidosis. Further observations. Dig Dis Sci 29:353–356PubMed
169.
go back to reference Devaney K, Goodman ZD, Epstein MS et al (1993) Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 17:1272–1280PubMed Devaney K, Goodman ZD, Epstein MS et al (1993) Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 17:1272–1280PubMed
170.
go back to reference Lehmuskallio E, Hannuksela M, Halme H (1977) The liver in sarcoidosis. Acta Med Scand 202:289–293PubMed Lehmuskallio E, Hannuksela M, Halme H (1977) The liver in sarcoidosis. Acta Med Scand 202:289–293PubMed
171.
go back to reference Chamuleau RA, Sprangers RL, Alberts C et al (1985) Sarcoidosis and chronic intrahepatic cholestasis. Neth J Med 28:470–476PubMed Chamuleau RA, Sprangers RL, Alberts C et al (1985) Sarcoidosis and chronic intrahepatic cholestasis. Neth J Med 28:470–476PubMed
172.
go back to reference Warshauer DM, Dumbleton SA, Molina PL et al (1994) Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology 192:93–98PubMed Warshauer DM, Dumbleton SA, Molina PL et al (1994) Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology 192:93–98PubMed
173.
go back to reference Warshauer DM, Molina PL, Hamman SM et al (1995) Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 195:757–762PubMed Warshauer DM, Molina PL, Hamman SM et al (1995) Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 195:757–762PubMed
174.
go back to reference Britt AR, Francis IR, Glazer GM et al (1991) Sarcoidosis: abdominal manifestations at CT. Radiology 178:91–94PubMed Britt AR, Francis IR, Glazer GM et al (1991) Sarcoidosis: abdominal manifestations at CT. Radiology 178:91–94PubMed
175.
go back to reference Folz SJ, Johnson CD, Swensen SJ (1995) Abdominal manifestations of sarcoidosis in CT studies. J Comput Assist Tomogr 19:573–579PubMed Folz SJ, Johnson CD, Swensen SJ (1995) Abdominal manifestations of sarcoidosis in CT studies. J Comput Assist Tomogr 19:573–579PubMed
176.
go back to reference Selroos O (1976) Sarcoidosis of the spleen. Acta Med Scand 200:337–340PubMed Selroos O (1976) Sarcoidosis of the spleen. Acta Med Scand 200:337–340PubMed
177.
go back to reference Kataria YP, Whitcomb ME (1980) Splenomegaly in sarcoidosis. Arch Intern Med 140:35–37PubMed Kataria YP, Whitcomb ME (1980) Splenomegaly in sarcoidosis. Arch Intern Med 140:35–37PubMed
178.
go back to reference Sharma OP, Vucinic V, James DG (2002) Splenectomy in sarcoidosis: indications, complications, and long-term follow-up. Sarcoidosis Vasc Diffuse Lung Dis 19:66–70PubMed Sharma OP, Vucinic V, James DG (2002) Splenectomy in sarcoidosis: indications, complications, and long-term follow-up. Sarcoidosis Vasc Diffuse Lung Dis 19:66–70PubMed
179.
go back to reference Panselinas E, Halstead L, Schlosser RJ et al (2010) Clinical manifestations, radiographic findings, treatment options, and outcome in sarcoidosis patients with upper respiratory tract involvement. South Med J 103:870–875PubMed Panselinas E, Halstead L, Schlosser RJ et al (2010) Clinical manifestations, radiographic findings, treatment options, and outcome in sarcoidosis patients with upper respiratory tract involvement. South Med J 103:870–875PubMed
180.
go back to reference Krespi YP, Mitrani M, Husain S et al (1987) Treatment of laryngeal sarcoidosis with intralesional steroid injection. Ann Otol Rhinol Laryngol 96:713–715PubMed Krespi YP, Mitrani M, Husain S et al (1987) Treatment of laryngeal sarcoidosis with intralesional steroid injection. Ann Otol Rhinol Laryngol 96:713–715PubMed
181.
go back to reference Rizzato G, Montemurro L (2000) The clinical spectrum of the sarcoid peripheral lymph node. Sarcoidosis Vasc Diffuse Lung Dis 17:71–80PubMed Rizzato G, Montemurro L (2000) The clinical spectrum of the sarcoid peripheral lymph node. Sarcoidosis Vasc Diffuse Lung Dis 17:71–80PubMed
182.
go back to reference Teirstein AS, Machac J, Almeida O et al (2007) Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 132:1949–1953PubMed Teirstein AS, Machac J, Almeida O et al (2007) Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 132:1949–1953PubMed
183.
go back to reference Rizzato G, Colombo P (1996) Nephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study. Sarcoidosis Vasc Diffuse Lung Dis 13:167–172PubMed Rizzato G, Colombo P (1996) Nephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study. Sarcoidosis Vasc Diffuse Lung Dis 13:167–172PubMed
184.
go back to reference Sharma OP (2005) Renal sarcoidosis and hypercalcemia. Eur Resp J Monog 32:220–232 Sharma OP (2005) Renal sarcoidosis and hypercalcemia. Eur Resp J Monog 32:220–232
185.
go back to reference Berliner AR, Haas M, Choi MJ (2006) Sarcoidosis: the nephrologist’s perspective. Am J Kidney Dis 48:856–870PubMed Berliner AR, Haas M, Choi MJ (2006) Sarcoidosis: the nephrologist’s perspective. Am J Kidney Dis 48:856–870PubMed
186.
go back to reference Casella FJ, Allon M (1993) The kidney in sarcoidosis. J Am Soc Nephrol 3:1555–1562PubMed Casella FJ, Allon M (1993) The kidney in sarcoidosis. J Am Soc Nephrol 3:1555–1562PubMed
187.
go back to reference Bell NH, Stern PH, Pantzer E et al (1979) Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 64:218–225PubMedCentralPubMed Bell NH, Stern PH, Pantzer E et al (1979) Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 64:218–225PubMedCentralPubMed
188.
go back to reference Adams JS, Gacad MA (1985) Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161:755–765PubMed Adams JS, Gacad MA (1985) Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161:755–765PubMed
189.
go back to reference Adams JS, Sharma OP, Gacad MA et al (1983) Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 72:1856–1860PubMedCentralPubMed Adams JS, Sharma OP, Gacad MA et al (1983) Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 72:1856–1860PubMedCentralPubMed
190.
go back to reference Cremers JP, Van Kroonenburgh MJ, Mostard RL et al (2014) Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis 31:37–45PubMed Cremers JP, Van Kroonenburgh MJ, Mostard RL et al (2014) Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis 31:37–45PubMed
191.
go back to reference Rubini G, Cappabianca S, Altini C et al (2014) Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis. Radiol Med 119:64–74PubMed Rubini G, Cappabianca S, Altini C et al (2014) Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis. Radiol Med 119:64–74PubMed
192.
go back to reference Mostard RL, Prompers L, Weijers RE et al (2012) F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med 37:21–25PubMed Mostard RL, Prompers L, Weijers RE et al (2012) F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med 37:21–25PubMed
193.
go back to reference Caobelli F, Gabanelli SV, Brucato A et al (2013) Unsuspected active sarcoidosis diagnosed by 18F-FDG PET/CT during the search for a primary tumour in a patient with bone lesions. Nucl Med Mol Imaging 47:205–207PubMedCentralPubMed Caobelli F, Gabanelli SV, Brucato A et al (2013) Unsuspected active sarcoidosis diagnosed by 18F-FDG PET/CT during the search for a primary tumour in a patient with bone lesions. Nucl Med Mol Imaging 47:205–207PubMedCentralPubMed
194.
go back to reference Montini KM, Tulchinsky M (2012) False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer. Clin Nucl Med 37:307–310PubMed Montini KM, Tulchinsky M (2012) False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer. Clin Nucl Med 37:307–310PubMed
195.
go back to reference Jansen TLTA, Geusens PPMM (2005) Sarcoidosis: joint, muscles, and bones. Eur Resp J Monog 32:210–219 Jansen TLTA, Geusens PPMM (2005) Sarcoidosis: joint, muscles, and bones. Eur Resp J Monog 32:210–219
196.
go back to reference Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064–1071PubMed Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064–1071PubMed
197.
go back to reference Clarencon F, Silbermann-Hoffman O, Lebreton C (2007) Diffuse spine involvement in sarcoidosis with sternal lytic lesions: two case reports. Spine 32:E594–597PubMed Clarencon F, Silbermann-Hoffman O, Lebreton C (2007) Diffuse spine involvement in sarcoidosis with sternal lytic lesions: two case reports. Spine 32:E594–597PubMed
198.
go back to reference Awada H, Abi-Karam G, Fayad F (2003) Musculoskeletal and other extrapulmonary disorders in sarcoidosis. Best Pract Res Clin Rheumatol 17:971–987PubMed Awada H, Abi-Karam G, Fayad F (2003) Musculoskeletal and other extrapulmonary disorders in sarcoidosis. Best Pract Res Clin Rheumatol 17:971–987PubMed
199.
go back to reference Patel A, Sun JH, Kim I et al (2013) GI tract sarcoidosis: a review. Pract Gastroenterol 37:25–38 Patel A, Sun JH, Kim I et al (2013) GI tract sarcoidosis: a review. Pract Gastroenterol 37:25–38
200.
go back to reference Mahevas M, Lescure FX, Boffa JJ et al (2009) Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 88:98–106 Mahevas M, Lescure FX, Boffa JJ et al (2009) Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 88:98–106
201.
go back to reference Lambert L, Riemer EC, Judson MA (2011) Rapid development of sarcoid tenosynovitis. J Clin Rheumatol 17:201–203PubMed Lambert L, Riemer EC, Judson MA (2011) Rapid development of sarcoid tenosynovitis. J Clin Rheumatol 17:201–203PubMed
202.
go back to reference El-Zawahry AM, Judson MA, Smith MT et al (2010) Genitourinary sarcoidosis: a single institution experience and review of the literature. UroToday Int J 3:1–6 El-Zawahry AM, Judson MA, Smith MT et al (2010) Genitourinary sarcoidosis: a single institution experience and review of the literature. UroToday Int J 3:1–6
203.
go back to reference Gisvold JJ, Crotty TB, Johnson RE (2000) Sarcoidosis presenting as spiculated breast masses. Mayo Clin Proc 75:293–295PubMed Gisvold JJ, Crotty TB, Johnson RE (2000) Sarcoidosis presenting as spiculated breast masses. Mayo Clin Proc 75:293–295PubMed
204.
go back to reference Allen SL, Judson MA (2010) Vaginal involvement in a patient with sarcoidosis. Chest 137:455–456PubMed Allen SL, Judson MA (2010) Vaginal involvement in a patient with sarcoidosis. Chest 137:455–456PubMed
205.
go back to reference JC R e S, De Sa Rosa e Silva AC, Aguiar FM (2006) Isolated endometrial polypoid sarcoidosis in a post-menopausal patient: case report. Maturitas 53:489–491 JC R e S, De Sa Rosa e Silva AC, Aguiar FM (2006) Isolated endometrial polypoid sarcoidosis in a post-menopausal patient: case report. Maturitas 53:489–491
206.
go back to reference Okumus G, Musellim B, Cetinkaya E et al (2011) Extrapulmonary involvement in patients with sarcoidosis in Turkey. Respirology 16:446–450PubMed Okumus G, Musellim B, Cetinkaya E et al (2011) Extrapulmonary involvement in patients with sarcoidosis in Turkey. Respirology 16:446–450PubMed
207.
go back to reference Judson MA, Baughman RP, Teirstein AS et al (1999) Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS research group. a case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:75–86PubMed Judson MA, Baughman RP, Teirstein AS et al (1999) Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS research group. a case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:75–86PubMed
208.
go back to reference Judson MA, Costabel U, Drent M et al (2014) The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis 31:19–27PubMed Judson MA, Costabel U, Drent M et al (2014) The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis 31:19–27PubMed
209.
go back to reference de Kleijn WP, De Vries J, Lower EE et al (2009) Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med 15:499–506PubMed de Kleijn WP, De Vries J, Lower EE et al (2009) Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med 15:499–506PubMed
210.
go back to reference De Vries J, Drent M (2004) Relationship between perceived stress and sarcoidosis in a Dutch patient population. Sarcoidosis Vasc Diffuse Lung Dis 21:57–63PubMed De Vries J, Drent M (2004) Relationship between perceived stress and sarcoidosis in a Dutch patient population. Sarcoidosis Vasc Diffuse Lung Dis 21:57–63PubMed
211.
go back to reference Gvozdenovic BS, Mihailovic-Vucinic V, Ilic-Dudvarski A et al (2008) Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir Med 102:1636–1642PubMed Gvozdenovic BS, Mihailovic-Vucinic V, Ilic-Dudvarski A et al (2008) Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir Med 102:1636–1642PubMed
212.
go back to reference De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP et al (2004) The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 21:127–136PubMed De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP et al (2004) The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 21:127–136PubMed
213.
go back to reference De Vries J, Lower EE, Drent M (2010) Quality of life in sarcoidosis: assessment and management. Semin Respir Crit Care Med 31:485–493PubMed De Vries J, Lower EE, Drent M (2010) Quality of life in sarcoidosis: assessment and management. Semin Respir Crit Care Med 31:485–493PubMed
214.
go back to reference Chang B, Steimel J, Moller DR et al (2001) Depression in sarcoidosis. Am J Respir Crit Care Med 163:329–334PubMed Chang B, Steimel J, Moller DR et al (2001) Depression in sarcoidosis. Am J Respir Crit Care Med 163:329–334PubMed
215.
go back to reference Patterson KC, Huang F, Oldham JM et al (2013) Excessive daytime sleepiness and obstructive sleep apnea in patients with sarcoidosis. Chest 143:1562–1568PubMed Patterson KC, Huang F, Oldham JM et al (2013) Excessive daytime sleepiness and obstructive sleep apnea in patients with sarcoidosis. Chest 143:1562–1568PubMed
216.
go back to reference Drent M, Wirnsberger RM, de Vries J et al (1999) Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J 13:718–722PubMed Drent M, Wirnsberger RM, de Vries J et al (1999) Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J 13:718–722PubMed
217.
go back to reference De Vries J, Drent M, Van Heck GL et al (1998) Quality of life in sarcoidosis: a comparison between members of a patient organisation and a random sample. Sarcoidosis Vasc Diffuse Lung Dis 15:183–188PubMed De Vries J, Drent M, Van Heck GL et al (1998) Quality of life in sarcoidosis: a comparison between members of a patient organisation and a random sample. Sarcoidosis Vasc Diffuse Lung Dis 15:183–188PubMed
218.
go back to reference De Vries J, Michielsen H, Van Heck GL et al (2004) Measuring fatigue in sarcoidosis: the fatigue assessment scale (FAS). Br J Health Psychol 9:279–291PubMed De Vries J, Michielsen H, Van Heck GL et al (2004) Measuring fatigue in sarcoidosis: the fatigue assessment scale (FAS). Br J Health Psychol 9:279–291PubMed
219.
go back to reference Kalkanis A, Yucel RM, Judson MA (2013) The internal consistency of PRO fatigue instruments in sarcoidosis: superiority of the PFI over the FAS. Sarcoidosis Vasc Diffuse Lung Dis 30:60–64PubMed Kalkanis A, Yucel RM, Judson MA (2013) The internal consistency of PRO fatigue instruments in sarcoidosis: superiority of the PFI over the FAS. Sarcoidosis Vasc Diffuse Lung Dis 30:60–64PubMed
220.
go back to reference Lower EE, Harman S, Baughman RP (2008) Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. Chest 133:1189–1195PubMed Lower EE, Harman S, Baughman RP (2008) Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. Chest 133:1189–1195PubMed
221.
go back to reference Victorson DE, Cella D, Grund H, et al. A conceptual model of health-related quality of life in sarcoidosis. Qual Life Res 2013 Victorson DE, Cella D, Grund H, et al. A conceptual model of health-related quality of life in sarcoidosis. Qual Life Res 2013
222.
go back to reference Victorson DE, Choi S, Judson MA et al (2014) Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis. Qual Life Res 23:1301–1313PubMed Victorson DE, Choi S, Judson MA et al (2014) Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis. Qual Life Res 23:1301–1313PubMed
223.
go back to reference Hoitsma E, De Vries J, van Santen-Hoeufft M et al (2003) Impact of pain in a Dutch sarcoidosis patient population. Sarcoidosis Vasc Diffuse Lung Dis 20:33–39PubMed Hoitsma E, De Vries J, van Santen-Hoeufft M et al (2003) Impact of pain in a Dutch sarcoidosis patient population. Sarcoidosis Vasc Diffuse Lung Dis 20:33–39PubMed
224.
go back to reference Kobak S, Sever F, Ince O et al (2014) The prevalence of sacroiliitis and spondyloarthritis in patients with sarcoidosis. Int J Rheumatol 2014:289454PubMedCentralPubMed Kobak S, Sever F, Ince O et al (2014) The prevalence of sacroiliitis and spondyloarthritis in patients with sarcoidosis. Int J Rheumatol 2014:289454PubMedCentralPubMed
225.
go back to reference Erb N, Cushley MJ, Kassimos DG et al (2005) An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis. Chest 127:192–196PubMed Erb N, Cushley MJ, Kassimos DG et al (2005) An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis. Chest 127:192–196PubMed
226.
go back to reference Yanardag H, Pamuk ON, Kiziltan M et al (2003) An increased frequency of carpal tunnel syndrome in sarcoidosis. Results of a study based on nerve conduction study. Acta Med (Hradec Kralove) 46:201–204 Yanardag H, Pamuk ON, Kiziltan M et al (2003) An increased frequency of carpal tunnel syndrome in sarcoidosis. Results of a study based on nerve conduction study. Acta Med (Hradec Kralove) 46:201–204
227.
go back to reference Niemer GW, Bolster MB, Buxbaum L et al (2001) Carpal tunnel syndrome in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:296–300PubMed Niemer GW, Bolster MB, Buxbaum L et al (2001) Carpal tunnel syndrome in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:296–300PubMed
228.
go back to reference Kersting-Sommerhoff B, Hof N, Golder W (1995) MRI of the wrist joint: “granulomatous tenovaginitis of the sarcoidosis type”—a rare cause of carpal tunnel syndrome. Rontgenpraxis 48:206–208PubMed Kersting-Sommerhoff B, Hof N, Golder W (1995) MRI of the wrist joint: “granulomatous tenovaginitis of the sarcoidosis type”—a rare cause of carpal tunnel syndrome. Rontgenpraxis 48:206–208PubMed
229.
go back to reference De Vries J, Wirnsberger RM (2005) Fatigue, quality of life and health status in sarcoidosis. Eur Respir Mon 32:92–104 De Vries J, Wirnsberger RM (2005) Fatigue, quality of life and health status in sarcoidosis. Eur Respir Mon 32:92–104
230.
go back to reference Denny MC, Fotino AD (2013) The Heerfordt–Waldenstrom syndrome as an initial presentation of sarcoidosis. Proc (Bayl Univ Med Cent) 26:390–392 Denny MC, Fotino AD (2013) The Heerfordt–Waldenstrom syndrome as an initial presentation of sarcoidosis. Proc (Bayl Univ Med Cent) 26:390–392
231.
go back to reference Petropoulos IK, Zuber JP, Guex-Crosier Y (2008) Heerfordt syndrome with unilateral facial nerve palsy: a rare presentation of sarcoidosis. Klin Monbl Augenheilkd 225:453–456PubMed Petropoulos IK, Zuber JP, Guex-Crosier Y (2008) Heerfordt syndrome with unilateral facial nerve palsy: a rare presentation of sarcoidosis. Klin Monbl Augenheilkd 225:453–456PubMed
232.
go back to reference Evanchan J, Barreiro TJ, Gemmel D (2010) Uveitis, salivary gland swelling, and facial nerve palsy in a febrile woman. Jaapa 23(46):48–50 Evanchan J, Barreiro TJ, Gemmel D (2010) Uveitis, salivary gland swelling, and facial nerve palsy in a febrile woman. Jaapa 23(46):48–50
233.
go back to reference Judson MA (2008) The diagnosis of sarcoidosis. Clin Chest Med 29:415–427, viiiPubMed Judson MA (2008) The diagnosis of sarcoidosis. Clin Chest Med 29:415–427, viiiPubMed
234.
go back to reference Neville E, Mills RG, Jash DK et al (1976) Sarcoidosis of the upper respiratory tract and its association with lupus pernio. Thorax 31:660–664PubMedCentralPubMed Neville E, Mills RG, Jash DK et al (1976) Sarcoidosis of the upper respiratory tract and its association with lupus pernio. Thorax 31:660–664PubMedCentralPubMed
235.
go back to reference James DG, Barter S, Jash D et al (1982) Sarcoidosis of the upper respiratory tract (SURT). J Laryngol Otol 96:711–718PubMed James DG, Barter S, Jash D et al (1982) Sarcoidosis of the upper respiratory tract (SURT). J Laryngol Otol 96:711–718PubMed
Metadata
Title
The Clinical Features of Sarcoidosis: A Comprehensive Review
Author
Marc A. Judson
Publication date
01-08-2015
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 1/2015
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-014-8450-y

Other articles of this Issue 1/2015

Clinical Reviews in Allergy & Immunology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.